← Browse by Condition
Medical Condition

transthyretin amyloidosis with cardiomyopathy

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT07052903 Phase 3
Recruiting

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Enrollment
1,250 pts
Location
United States, Argen...
Sponsor
Alnylam Pharmaceuticals
View Trial →